LIVE
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antih. Track Solara Active Pharma Sciences Limited's live NSE:SOLARA share price ₹517.20 (+0.71%), market cap ₹₹25B. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for SOLARA — real-time NSE India stock intelligence.
Open
₹522.85
High
₹522.85
Low
₹513.55
Prev. Close
₹513.55
52W High
₹712.00
52W Low
₹422.00
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antih
Key Takeaway
Solara Active Pharma Sciences Limited is rated none with a P/E of —x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is Solara Active Pharma Sciences Limited fairly valued right now?
Because a P/E of —x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting Solara Active Pharma Sciences Limited
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
382 Cr
Revenue
16 Cr
Net Profit
0%
ROE
0%
ROCE
-0.62
EPS
| ₹ in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 1,379 | 1,238 | 1,284 | 1,369 | 1,432 |
| Net Profit | -22 | -567 | 1 | -7 | -1 |
| ROE (%) | — | — | — | 0.0% | 0.0% |
| EPS (₹) | — | — | — | -0.62 | -0.62 |
| Debt/Equity | — | — | — | 54.7 | 54.7 |